MDS Nordion to develop advanced external beam therapy system
30 Settembre 2004 - 11:00AM
PR Newswire (US)
MDS Nordion to develop advanced external beam therapy system New
unit will provide cancer clinics with greater flexibility to offer
range of treatments OTTAWA, Sept. 30 /PRNewswire-FirstCall/ -- MDS
Nordion announced today plans to develop a new external beam
radiation therapy system for the treatment of cancer. The new
system will provide cancer care professionals with greater clinical
flexibility to offer a wide range of treatments from the simple to
the more complex. The modern functionality of this next generation
unit will allow clinics to maximize productivity while offering the
most advanced cancer care. The new unit continues in the tradition
of MDS Nordion's THERATRON(R) family of cancer treatment machines -
providing cost-effective solutions to enable greater access to
quality cancer care. "With an ever-growing demand, the need to
improve timely access to cancer treatment is increasingly a concern
in the global cancer-care community," says Dr. Laval Grimard, Head
of Radiation Oncology at the Ottawa Hospital Regional Cancer Centre
in Ottawa, Canada. "Cancer care professionals need efficient and
effective tools to manage the workload." The new system will
feature asymmetrical jaws and motorized wedge for expanded
treatment possibilities and integrated operations will ensure
accurate and reproducible treatment set-ups. In addition, ergonomic
hand controls, a state-of-the-art treatment table and user-friendly
graphical interface all contribute to maximizing efficiencies
allowing clinics to treat more patients per day. "The challenges in
modern oncology are overwhelming. Throughout the world, the rates
of cancer are rising, putting an increased burden on resources as
well as timely access to treatments," says John Corley, Senior Vice
President, Ion Technologies at MDS Nordion. "The new external beam
therapy system from MDS Nordion will enable busy clinics to provide
more complex treatments while at the same time improve and better
manage the workload." Every day, some 1200 MDS Nordion THERATRON
external beam radiation therapy systems deliver more than 45,000
cancer treatments in over 80 countries. According to the World
Cancer Report, global cancer rates are expected to increase 50
percent to 15 million new cases by the year 2020. The unit will
expand the treatment possibilities and meet the clinical and
productivity demands of radiation oncology departments around the
world. The new MDS Nordion external beam therapy unit will provide
the global cancer care community with an efficient tool that will
expand treatment possibilities and advance cancer care worldwide.
To learn more about this new external beam radiation therapy
system, visit MDS Nordion at the following scientific meetings: the
ONCO oncology congress, October 5 - 9 in Havana, Cuba; the European
Society of Therapeutic Radiology and Oncology (ESTRO), October 24 -
28 in Amsterdam, The Netherlands; the International Conference on
Medical Physics (ICMP), October 28 - 31 in New Delhi, India; and
the Association of Radiation Oncologists India (AROI) November 25 -
28, in Ludhiana, India. About MDS Nordion MDS Nordion
(http://www.mds.nordion.com/) is a world leader in the
radioisotopes, radiation and related technologies. MDS Nordion is
part of MDS Inc. At MDS Inc., our 10,000 highly skilled people
provide services, products and instruments enabling health sciences
organizations to enhance the well being of people around the world.
We focus on helping discover and test new drugs, assisting doctors
to diagnose and treat patients and preventing the spread of
disease. Find out more about MDS Inc. (TSX: MDS; NYSE: MDZ), at
http://www.mdsintl.com/ or by calling 1-888-MDS-7222, 24 hours a
day. DATASOURCE: MDS Nordion CONTACT: Olivia Nixon, Media
Relations, MDS Nordion, Tel: (613) 592-3400 ext. 2832, E-mail:
Copyright